Download PDF
Adipositas - Ursachen, Folgeerkrankungen, Therapie 2024; 18(03): 107-110
DOI: 10.1055/a-2340-0837
Review

Adipositasleitlinie 2024 – was ist neu?

Obesity Guideline 2024 – What’s New?
Hans Hauner
1   Institut für Ernährungsmedizin, Else Kröner Fresenius Zentrum für Ernährungsmedizin, TUM School of Medicine and Health, München, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Nach Aktualisierung und Erweiterung steht seit kurzem die neue S3-Leitlinie zur „Prävention und Therapie der Adipositas“ zur Verfügung. Sie enthält erstmalig ein Kapitel zur weit verbreiteten Stigmatisierung von Menschen mit Adipositas, die sich durch alle Lebens-bereiche zieht, sowie ein Kapitel zu den digitalen Behandlungsmöglichkeiten, die zunehmend genutzt werden. Die neuen gewichtssenkenden Medikamente stellen eine effektive Bereicherung der Therapieoptionen dar und können vor allem die Lücke zwischen der multimodalen Basistherapie und der bariatrischen Chirurgie füllen. Damit wird sich die Adipositastherapie in den nächsten Jahren deutlich verändern und die aktualisierte Leitlinie soll einen Beitrag leisten, um moderne Adipositasmedizin besser ins deutsche Gesundheits-system zu integrieren.

Abstract

After the recent update and extension, the new version of the evidence-based S3-guideline for the „prevention and management of obesity“ is available. Two new chapters have been included, one on the widespread stigmatization of people with obesity in many areas and the other one on the already frequently used digital treatment options. Novel weight-lowering drugs represent another effective treatment option that has the potential to close the gap between the multimodal lifestyle treatments and bariatric surgery. Without doubt, there will be substantial changes in the management of obesity in the coming years and the updated guideline is needed to support the implementation of obesity medicine in the German healthcare system.

Schlüsselwörter

Adipositas - Prävention - Behandlung - Pharmakotherapie - digitale Behandlung - Leitlinien

Keywords

Obesity - prevention - management - guidelines - pharmacotherapy - digital treatment


Publication History

Article published online:
20 September 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Astbury NM, Piernas C, Hartmann-Boyce J. et al. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes Rev 2019; 20: 569-587
    CrossrefPubMedGoogle Scholar
  • 2 Blundell JE, Dulloo AG, Salvador J. et al. Beyond BMI – phenotyping the obesities. Obes Facts 2014; 7: 322-328
    CrossrefPubMedGoogle Scholar
  • 3 Churuangsuk C, Kherouf M, Combet E. et al. Low-carbohydrate diets for overweight and obesity: a systematic review of the systematic reviews. Obes Rev 2018; 19: 1700-1718
    CrossrefPubMedGoogle Scholar
  • 4 Deutsche Adipositas Gesellschaft et al. Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“. AWMF-Register-Nr. 050/001, Mai 2024
    PubMed
  • 5 Gemesi K, Winkler S, Schmidt-Tesch S. et al. Efficacy of an app-based multimodal lifestyle intervention on body weight in persons with obesity: results from a randomised controlled trial. Int J Obes 2024; 48: 418-426
    CrossrefPubMedGoogle Scholar
  • 6 Hartmann-Boyce J, Johns DJ, Jebb SA. et al. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev 2014; 15: 920-932
    CrossrefPubMedGoogle Scholar
  • 7 Huang R-Y, Huang CC, Hu FB. et al. Vegetarian diets and weight reduction: a meta-analysis of randomized controlled trials. J Gen Intern Med 2016; 31: 109-116
    CrossrefPubMedGoogle Scholar
  • 8 Lincoff AM, Brown-Frandsen K, Colhoun HM. et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med 2023; 389: 2221-2232
    CrossrefPubMedGoogle Scholar
  • 9 Mancini JG, Filion KB, Atallah R. et al. Systematic review of the Medterranean diet for long-term weight loss. Am J Med 2016; 129: 407-415
    CrossrefPubMedGoogle Scholar
  • 10 Morris E, Jebb SA, Oke J. et al. Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes. Br J Gen Pract 2021; 71: e312-e319
    CrossrefPubMedGoogle Scholar
  • 11 Paixao C, Dias CM, Jorge R. et al. Successful weight loss maintenance: a systematic review of weight control registries. Obes Rev 2020; 21: e13003
    CrossrefPubMedGoogle Scholar
  • 12 Parretti HM, Jebb SA, Johns DJ. et al. Clinical effectiveness of very-low-calorie diets in the management of weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2016; 17: 224-234
    CrossrefPubMedGoogle Scholar
  • 13 Pearl RL, Puhl RM. Weight bias internalization and health. Obes Rev 2018; 19: 1141-1163
    CrossrefPubMedGoogle Scholar
  • 14 Roth L, Ordnung M, Forkmann K. et al. A randomized-controlled trial to evaluate the app-based multimodal weight loss program zanadio for patients with obesity. Obesity 2013; 31: 1300-1310
    CrossrefPubMedGoogle Scholar
  • 15 Varkevisser RDM, van Stralen MM, Kroeze W. et al. Determinants of weight loss maintenance: a systematic review. Obes Rev 2019; 20: 171-211
    CrossrefPubMedGoogle Scholar
  • 16 WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Report Series 894, 2000
    PubMed
  • 17 Wirth A, Wabitsch M, Hauner H. Klinische Leitlinie: Prävention und Therapie der Adipositas. Dtsch Arztebl Int 2014; 111: 705-713
    CrossrefPubMedGoogle Scholar